Neuropediatrics 2014; 45(04): 256-260
DOI: 10.1055/s-0033-1363300
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Fulminant Encephalopathy with Marked Brain Edema and Bilateral Thalamic Lesions

Naoki Ando
1   Department of Pediatrics, Nagoya City University Graduate School of Medicine, Nagoya, Japan
,
Akihisa Okumura
2   Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
,
Satoru Kobayashi
1   Department of Pediatrics, Nagoya City University Graduate School of Medicine, Nagoya, Japan
,
Yutaka Negishi
1   Department of Pediatrics, Nagoya City University Graduate School of Medicine, Nagoya, Japan
,
Ayako Hattori
1   Department of Pediatrics, Nagoya City University Graduate School of Medicine, Nagoya, Japan
,
Tohru Okanishi
1   Department of Pediatrics, Nagoya City University Graduate School of Medicine, Nagoya, Japan
,
Shinpei Abe
2   Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
,
Mitsuru Ikeno
2   Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
,
Ayuko Igarashi
2   Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
,
Shinji Saitoh
1   Department of Pediatrics, Nagoya City University Graduate School of Medicine, Nagoya, Japan
,
Toshiaki Shimizu
2   Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
› Author Affiliations
Further Information

Publication History

29 June 2013

09 October 2013

Publication Date:
13 December 2013 (online)

Abstract

We encountered two children with acute encephalopathy associated with unique clinical manifestations. Both the patients had status epilepticus at onset and neuroimaging studies revealed marked brain edema and bilateral thalamic lesions. Although they were treated with steroids and immunoglobulin, their outcomes were very poor. A thermolabile variant of carnitine palmitoyltransferase II and an elevated interleukin-6 level in cerebrospinal fluid were observed in one patient each. The constellation of clinical and neuroimaging findings in our patients is apparently not consistent with any established subtype of acute encephalopathy/encephalitis.

 
  • References

  • 1 Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev 1997; 19 (2) 81-92
  • 2 Mizuguchi M, Abe J, Mikkaichi K , et al. Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry 1995; 58 (5) 555-561
  • 3 Takanashi J. Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev 2009; 31 (7) 521-528
  • 4 Shewmon DA. Chronic “brain death”: meta-analysis and conceptual consequences. Neurology 1998; 51 (6) 1538-1545
  • 5 Mizuguchi M, Hayashi M, Nakano I , et al. Concentric structure of thalamic lesions in acute necrotizing encephalopathy. Neuroradiology 2002; 44 (6) 489-493
  • 6 Wong AM, Simon EM, Zimmerman RA, Wang HS, Toh CH, Ng SH. Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome. AJNR Am J Neuroradiol 2006; 27 (9) 1919-1923
  • 7 Ozdoba C, Pfenninger J, Schroth G. Initial and follow-up MRI in a case of early diagnosed Reye's syndrome. Neuroradiology 1997; 39 (7) 495-498
  • 8 Singh P, Goraya JS, Gupta K, Saggar K, Ahluwalia A. Magnetic resonance imaging findings in Reye syndrome: case report and review of the literature. J Child Neurol 2011; 26 (8) 1009-1014
  • 9 Johnsen SD, Bird CR. The thalamus and midbrain in Reye syndrome. Pediatr Neurol 2006; 34 (5) 405-407
  • 10 Levin M, Hjelm M, Kay JD , et al. Haemorrhagic shock and encephalopathy: a new syndrome with a high mortality in young children. Lancet 1983; 2 (8341) 64-67
  • 11 Glauser TA, Pachter LM, Zimmerman RA. Abnormal magnetic resonance images in hemorrhagic shock and encephalopathy syndrome. J Child Neurol 1992; 7 (4) 371-374
  • 12 Vles JS, de Vries LS, Wilms G, de Roo M, Casaer PJ. Computed cranial tomography, magnetic resonance imaging and single photon emission computed tomography in hemorrhagic shock and encephalopathy syndrome: a report of three cases. Neuropediatrics 1992; 23 (1) 24-27
  • 13 Toyoshima M, Maegaki Y, Sugihara S, Ohno K. Serial diffusion-weighted MRI in hemorrhagic shock and encephalopathy syndrome. Pediatr Neurol 2007; 36 (1) 66-69
  • 14 Levin M, Pincott JR, Hjelm M , et al. Hemorrhagic shock and encephalopathy: clinical, pathologic, and biochemical features. J Pediatr 1989; 114 (2) 194-203
  • 15 Bacon CJ, Hall SM. Haemorrhagic shock encephalopathy syndrome in the British Isles. Arch Dis Child 1992; 67 (8) 985-993
  • 16 Chen Y, Mizuguchi H, Yao D , et al. Thermolabile phenotype of carnitine palmitoyltransferase II variations as a predisposing factor for influenza-associated encephalopathy. FEBS Lett 2005; 579 (10) 2040-2044
  • 17 Shinohara M, Saitoh M, Takanashi J , et al. Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases. Brain Dev 2011; 33 (6) 512-517
  • 18 Kubota M, Chida J, Hoshino H , et al. Thermolabile CPT II variants and low blood ATP levels are closely related to severity of acute encephalopathy in Japanese children. Brain Dev 2012; 34 (1) 20-27
  • 19 Matsumoto H, Hatanaka D, Ogura Y, Chida A, Nakamura Y, Nonoyama S. Severe human herpesvirus 6-associated encephalopathy in three children: analysis of cytokine profiles and the carnitine palmitoyltransferase 2 gene. Pediatr Infect Dis J 2011; 30 (11) 999-1001
  • 20 Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, Furukawa S. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis 2003; 35 (1) 59-61
  • 21 Ichiyama T, Ito Y, Kubota M, Yamazaki T, Nakamura K, Furukawa S. Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection. Brain Dev 2009; 31 (10) 731-738
  • 22 Otake Y, Yamagata T, Morimoto Y , et al. Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev 2007; 29 (2) 117-120